Quality of life and utility in irradiated laryngeal cancer patients

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 4, 2000, Pages 875-881

  Ringash, Jolie ^a,b   Redelmeier, Donald A ^b   O'Sullivan, Brian ^a,b   Bezjak, Andrea ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Carcinoma of larynx; FACT H and N; Quality of life; Radiotherapy; Time trade off

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENCE RISK;

AGED; ANALYSIS OF VARIANCE; DECISION SUPPORT TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; GLOTTIS; HEALTH STATUS INDICATORS; HUMANS; LARYNGEAL NEOPLASMS; MALE; PATIENT PARTICIPATION; QUALITY OF LIFE; QUESTIONNAIRES; SEX FACTORS;

EID: 0034237459     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00560-5     Document Type: Article

References (51)

1. Trotti A, Emami B, Endicott J; et al. A randomized study of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord. RTOG protocol 95-12. http://www.rtog.org/members/protocols/95-12/.
2. Goepfert H, Weber S, Forastiere A; et al. Phase III trial to preserve the larynx: Induction chemotherapy and radiation therapy versus concomitant chemotherapy and radiation therapy versus radiation therapy. RTOG protocol 91-11. http://www.rtog.org/members/protocols/91-11/.
3. Stalpers L.J.A., Verbeek A.L.M., van Daal W.A.J. Radiotherapy or surgery for T2N0M0 glottic carcinoma? A decision-analytic approach. Radiother Oncol. 14:1989;209-217.
4. O'Sullivan B., Mackillop W., Gilbert R., et al. Controversies in the management of laryngeal cancer Results of an international survey of patterns of care . Radiother Oncol. 31:1994;23-32.
5. Bowling A. Measuring disease. 1995;3 Open University Press, Bristol, PA.
6. Torrance G.W. Utility approach to measuring health-related quality of life. J Chron Dis. 40:1987;593-600.
7. Fryback D.G., Dasbach E.J., Klein R., et al. The Beaver Dam Health Outcomes Study Initial catalog of health-state quality factors . Med Decis Making. 13:1993;89-102.
8. Fryback G.B., Lawrence W.F., Martin P.A., et al. Predicting quality of well-being scores from the SF-36 Results from the Beaver Dam Health Outcomes Study . Med Decis Making. 17:1997;1-9.
9. de Graeff A., de Leewu R.J., Ros W.J.G., et al. A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck. 21:1999;291-296.
10. Hammerlid E., Mercke C., Sullivan M., et al. A prospective quality of life study of patients with laryngeal carcinoma by tumor stage and different radiation therapy schedules. Laryngoscope. 108:1998;747-759.
11. Bjordal K., Kaasa S., Mastekaasa A. Quality of life in patients treated for head and neck cancer A follow-up study 7 to 11 years after radiotherapy . Int J Radiat Oncol Biol Phys. 28:1994;847-856.
12. Stewart M.G., Chen A.Y., Stach C.B. Outcomes analysis of voice and quality of life in patients with laryngeal cancer. Arch Otolaryngol Head Neck Surg. 124:1998;143-148.
13. List M.A., Ritter-Sterr C.A., Baker T.M., et al. Longitudinal assessment of quality of life in laryngeal cancer patients. Head Neck. 18:1996;1-10.
14. Terrell J.E., Fisher S.G., Wolf G.T. Long-term quality of life after treatment of laryngeal cancer. Arch Otolaryngol Head Neck Surg. 124:1998;964-971.
15. Cella D.F. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Scales. Centre on Outcomes, Research and Education (CORE). 1997;Northwestern Healthcare and Northwestern University, Evanston.
16. Harwood A. Cancer of the larynx The Toronto experience . J Otolaryngol. 11:(Suppl.):1982;1-21.
17. List M.A., D'Antonio L.L., Cella D.F., et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy - Head and neck scale. Cancer. 77:(11):1996;2294-2300.
18. D'Antonio L.L., Zimmerman G.J., Cella D.F., et al. Quality of life and functional status measures in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 122:1996;482-487.
19. D'Antonio L.L., Long S.A., Zimmerman G.J., et al. Relationship between quality of life and depression in patients with head and neck cancer. Laryngoscope. 108:1998;806-811.
20. Long S.A., D'Antonio L.L., Robinson E.B., et al. Factors related to quality of life and functional status in 50 patients with head and neck cancer. Laryngoscope. 106:1996;1084-1088.
21. List M.A., Mumby P., Haraf D., et al. Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Qual Life Res. 6:1997;274-283.
22. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy scale Development and validation of the general measure . J Clin Oncol. 11:(3):1993;570-579.
23. Harrison L.B., Zelefsky M.J., Pfister D.G., et al. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck. 19:1997;169-175.
24. Ruhl C.M., Gleich L.L., Gluckman J.L. Survival, function and quality of life after total glossectomy. Laryngoscope. 107:1997;1316-1321.
25. Torrance G.W., Thomas W.H., Sackett D.L. A utility maximization model for evaluation of health care programs. Health Serv Res. 7:1972;118-133.
26. Pliskin J.S., Shepard D.S., Weinstein M.D. Utility function for life years and health status. Oper Res. 28:1980;206-224.
27. Feeny D.H., Torrance G.W. Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples. Med Care. 27:(Suppl. 3):1989;S190-S204.
28. McNeil B.J., Weichselbaum R., Pauker S.G. Speech and survival Tradeoffs between quality and quantity of life in laryngeal cancer . N Engl J Med. 305:1981;982-987.
29. van der Donk J., Levendag P.C., Kuijpers A.J., et al. Patient participation in clinical decision-making for treatment of T3 laryngeal cancer A comparison of state and process utilities . J Clin Oncol. 13:1995;2369-2378.
30. Llewellyn-Thomas H.A., Sutherland H.J., Thiel E.C. Do patients' evaluations of a future health state change when they actually enter that state? Med Care. 31:1993;1002-1012.
31. Llewellyn-Thomas H.A., Sutherland H.J., Ciampi A., et al. The assessment of values in laryngeal cancer Reliability of measurement methods . J Chron Dis. 37:1984;283-291.
32. Llewellyn-Thomas H.A., Thiel E.C., McGreal M.J. Cancer patients' evaluations of their current health states The influences of expectations, comparisons, actual health status and mood . Med Decis Making. 12:1992;115-122.
33. de Haes J.C.J.M., Stiggelbout A.M. Assessment of values, utilities and preferences in cancer patients. Cancer Treat Rev. 22:(Suppl. A):1996;13-26.
34. Torrance G.W. Social preferences for health states An empirical evaluation of three measurement techniques . Socio-Econ Plan Sci. 10:1976;128-136.
35. Wolfson A., Sinclair A., Bombardier C., et al. Preference measures for functional status in stroke patients. Interrater and intertechnique comparisons. Kane R.L., Dane R.A. Values and long-term care. 1982;191-214 Lexington Books, Lexington, MA.
36. Read J.L., Quinn R.J., Berwick D.M., et al. Preferences for health outcomes Comparison of assessment method . Med Decis Making. 4:1984;315-329.
37. Stiggelbout A.M., Kiebert G.M., Kieviet J., et al. The "utility" of the time trade-off method in cancer patients Feasibility and proportional trade-off . J Clin Epidemiol. 48:1995;1207-1214.
38. Furlong W., Feeny D., Torrance G.W., et al. Guide to design and development of health-state utility instrumentation. 1990;McMaster University, Hamilton, ON.
39. Karnofsky D.A., Burchenal J.H. The clinical evaluation of chemotherapeutic agents in cancer. Macleod C.M. Evaluation of chemotherapeutic agents. 1949;191-205 Columbia University Press, New York.
40. Deshmane V.H., Parikh H.K., Pinni S., et al. Laryngectomy A quality of life assessment . Indian J Cancer. 32:1995;121-130.
41. Morton R.P. Laryngeal cancer Quality-of-life and cost-effectiveness . Head Neck. 19:1997;243-250.
42. Wolf G., Hong W., Fisher S., et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced larygeal cancer. N Engl J Med. 324:1991;1685-1690.
43. Finizia C., Hammerlid E., Westin T., et al. Quality of life and voice in patients with larygeal carcinoma A posttreatment comparison of larygectomy (salvage surgery) versus radiotherapy . Larygoscope. 108:1998;1566-1573.
44. DeSanto L.W., Olsen K.D., Perry W.C., et al. Quality of life after surgical treatment of cancer of the larynx. Ann Otol Rhinol Laryngol. 104:1995;763-769.
45. Revicki D.A., Kaplan R.M. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res. 2:1993;477-487.
46. Hillers T.K., Guyatt G.H., Oldridge N., et al. Quality of life after myocardial infarction. J Clin Epidemiol. 47:1994;1287-1296.
47. Rutten-van Molken M.P.M.H., Custers F., Van Doorslaer E.K.A., et al. Comparison of the performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J. 8:1995;888-898.
48. Bosch J.L., Hunink M.G.M. The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication. Med Decis Making. 16:1996;217-225.
49. Hjermstad M.J., Fayers P.M., et al. Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire The QLQ-C30(+3) . J Clin Oncol. 16:1998;1188-1196.
50. Jenkinson C., Coulter A., Wright L. Short form 36 (SF36) health survey questionnaire Normative data for adults of working age . BMJ. 306:1993;1437-1440.
51. Brazier J.E., Harper R., Jones N.M.B., et al. Validating the SF-36 survey questionnaire New outcome measure for primary care . BMJ. 305:1992;160-166.